Newswise — Bethesda, Md. – Sept. 14, 2016 – The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular diagnostic professionals, today announced the availability of complimentary media registration packages for its upcoming 2016 Annual Meeting. Media contacts from qualified print, online and broadcast news media outlets are invited to attend the meeting and learn about the latest advances in clinical molecular diagnostics.
When: Wednesday, November 9, 2016 – Saturday, November 12, 2016
Where: Charlotte Convention Center, Charlotte, NC
What: The four-day event will feature more than 2,000 attendees, 400 poster presentations, 200 exhibiting companies, and 60 educational sessions. The keynote speaker is the distinguished recipient of the 2016 AMP Award for Excellence in Molecular Diagnostics, Eric Lander, PhD, President and Founding Director of the Broad Institute of MIT and Harvard. Additional newsworthy topics include:• Emerging research for practical diagnostic approaches from liquid biopsies to immunotherapies to CHIP • Validation and regulation of laboratory developed processes to ensure quality testing• Protecting Access to Medicare Act of 2014 (PAMA), including what labs should be doing now• Leveraging big data to advance diagnostics• The human microbiome in health and disease
Why: Media registrants will be able to take advantage of the Press Room, as well as many new services and amenities including:• VIP seating in many of the presentations and workshops• Interviews with many influential speakers and exhibiting companies• Access to company news releases, press kit materials and event information• Electrical and wireless internet capabilities• Complimentary refreshments
Please contact Andrew Noble if you are interested in attending this year’s meeting and/or if you would like to be added to AMP’s media list.
ABOUT AMPThe Association for Molecular Pathology (AMP) was founded in 1995 to provide structure and leadership to the emerging field of molecular diagnostics. AMP's 2,300+ members practice in the various disciplines of molecular diagnostics, including bioinformatics, infectious diseases, inherited conditions, and oncology. They include individuals from academic and community medical centers, government, and industry; including pathologist and doctoral scientist laboratory directors; basic and translational scientists; technologists; and trainees. Through the efforts of its Board of Directors, Committees, Working Groups, and members, AMP is the primary resource for expertise, education, and collaboration in one of the fastest growing fields in healthcare. AMP members influence policy and regulation on the national and international levels, ultimately serving to advance innovation in the field and protect patient access to high quality, appropriate testing. For more information, visit www.amp.org.
MEDIA CONTACT:Andrew Nobleanoble@amp.org 415-722-2129###